title: [Complications of temporary transvenous endocardial pacemaker therapy].
abstract: The prospective analysis of the results of the temporary transvenous-endocardial pacemaker therapy in 591 cases of treatment resulted in a total rate of complications of 37.1%. Hereby the main part of complications were disturbances of the function of electrodes (28.3%). The greatest numbers of complications showed infiltrable electrode catheters which were applied at bedside with a dislocation rate of 17.2% and a rate of not achieved stable stimulation positions of 13.7%. The smallest numbers of complications were to be observed in semiflexible stimulation catheters, which were positioned under X-ray control (dislocations in 4.1%, no achievement of a stable stimulation position in 3.3%). For the practice of the temporary pacemaker therapy from this analysis result particularly consequences in the choice of a suitable stimulation catheter and the methodical approach in positioning of this catheter.
authors.affiliation: Klinik für Innere Medizin, Bereiches Medizin, Friedrich-Schiller-Universität Jena.
authors.forename: H
authors.initials: H
authors.lastname: Volkmann
authors.forename: R
authors.initials: R
authors.lastname: Paliege
authors.forename: H
authors.initials: H
authors.lastname: Kühnert
authors.forename: B
authors.initials: B
authors.lastname: Richter
authors.forename: G
authors.initials: G
authors.lastname: Dannberg
authors.forename: F
authors.initials: F
authors.lastname: Meier
mesh_terms: D000219:Adams-Stokes Syndrome / Q000628:therapy; D001145:Arrhythmias, Cardiac / Q000628:therapy*; D001919:Bradycardia / Q000628:therapy; D002408:Catheters, Indwelling / Q000009:adverse effects; D004562:Electrocardiography; D004630:Emergencies; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D011446:Prospective Studies; D012307:Risk Factors; D013610:Tachycardia / Q000628:therapy
vernacular_title: Komplikationen der temporären transvenös-endokardialen Schrittmachertherapie.